See All Slides - tctmd.com

Slides

Presentation TCT 2012

Preclinical Review: Experimental Models and Biological Considerations for the Validation of Heart Failure Devices

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Antonio Bartorelli

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

HFPEF: Overview of Pathophysiology and Therapies

Presenter: William Little

October 23, 2012

Presentation TCT 2012

Radial Artery Hemostasis and Occlusion

Presenter: Samir Pancholy

October 23, 2012

Presentation TCT 2012

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Presenter: Michael Haude

October 23, 2012

Presentation TCT 2012

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Presenter: Stefan Verheye

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(3)

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

Presenter: Shiro Uemura

October 23, 2012

Presentation TCT 2012

New Insights into Normal and Diseased Mitral Valve Anatomy

Presenter: David Adams

October 23, 2012

Advertisement

Slides

Preclinical Review: Experimental Models and Biological Considerations for the Validation of Heart Failure Devices

TCT-34. ABSORB EXTEND: An Interim Report on the 12-month Clinical Outcomes from the First 250 Patients Enrolled

Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain)

HFPEF: Overview of Pathophysiology and Therapies

Radial Artery Hemostasis and Occlusion

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve)

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(3)

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

New Insights into Normal and Diseased Mitral Valve Anatomy

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content